מטופלים
אגיאני היא השותפה לכל חולי פרקינסון, אנו מפתחים טיפולים חדשניים ומודרניים לטיפול במחלת פרקינסון.
המחויבות שלנו למטופלים
Together with patients, we are actively shaping a brighter future. Our objective is to achieve this through collaborative partnerships because we firmly believe that "Together, we are better." We are at the forefront of efforts to deepen our understanding of the root causes of Parkinson's Disease. Our team comprises clinicians, scientists, biotechnologists, and chemists who not only listen to patients and stakeholders but also strive to comprehend your stories with the aim of providing meaningful solutions to your challenges. Agyany shares a collective mission driven by your resilience, and we eagerly embrace the opportunity to accompany you on this journey.
המלצות
ניסויים קליניים
אגפי
גישה למטופלים
Agyany is dedicated to enhancing the well-being of individuals with PD and those at a heightened genetic risk of developing PD. Our commitment involves collaborating closely with patients and stakeholders, actively engaging with your narratives. Your words and stories serve as powerful catalysts, inspiring us to deepen our comprehension of PD's root causes and explore innovative treatment alternatives for a broader patient population.
While we firmly believe that participation in a clinical trial represents the optimal pathway to access new treatments, we recognize that this may not be feasible for every patient. In such situations, Agyany may consider the possibility of making compounds, such as ambroxol, available outside of a clinical trial.
